Research has extensively shown that astrocytes have the ability to control the attraction of tumor-associated macrophages (TAMs) to the tumor microenvironment (TME) through CCL2, leading to the progression of glioblastoma by encouraging a pro-tumor phenotype in TAMs (22). This evidence concerns the gene CCL2 and neoplasm.